Gurleen Kaur
@gurleenkaurmd.bsky.social
Cardiology Fellow at Brigham & Women's Hospital | CardioNerds Academy Program Director | Circulation Social Media Editor
Reposted by Gurleen Kaur
🚨 New @CircAHA #ESC2025 SimPub alert!
🚨 HCM isn’t just driven by rare Mendelian mutations. This study highlights the role of intermediate-effect variants (IEVs)—variants with moderate effect & low penetrance—in shaping disease expression. #HCM #SoMeEditor
tinyurl.com/HCM-IEVs
🚨 HCM isn’t just driven by rare Mendelian mutations. This study highlights the role of intermediate-effect variants (IEVs)—variants with moderate effect & low penetrance—in shaping disease expression. #HCM #SoMeEditor
tinyurl.com/HCM-IEVs
Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate Effect Variants | Circulation
Background: Hypertrophic cardiomyopathy (HCM) is a genetically heterogeneous disorder
primarily linked to rare variants in sarcomere genes, though recently certain non-sarcomeric
genes have emerged as...
tinyurl.com
August 29, 2025 at 2:52 PM
🚨 New @CircAHA #ESC2025 SimPub alert!
🚨 HCM isn’t just driven by rare Mendelian mutations. This study highlights the role of intermediate-effect variants (IEVs)—variants with moderate effect & low penetrance—in shaping disease expression. #HCM #SoMeEditor
tinyurl.com/HCM-IEVs
🚨 HCM isn’t just driven by rare Mendelian mutations. This study highlights the role of intermediate-effect variants (IEVs)—variants with moderate effect & low penetrance—in shaping disease expression. #HCM #SoMeEditor
tinyurl.com/HCM-IEVs
1/ In this #OriginalResearch paper in @ahajournals.bsky.social, Bellamo et al evaluate Lp(a) as a prognostic marker for incident and secondary vascular disease in participants from the UK Biobank
Here's a🧵summarizing key aspects of paper
🔗http://bit.ly/3HkLhP6
Let’s unpack the findings ⤵️
Here's a🧵summarizing key aspects of paper
🔗http://bit.ly/3HkLhP6
Let’s unpack the findings ⤵️
August 25, 2025 at 1:33 PM
1/ In this #OriginalResearch paper in @ahajournals.bsky.social, Bellamo et al evaluate Lp(a) as a prognostic marker for incident and secondary vascular disease in participants from the UK Biobank
Here's a🧵summarizing key aspects of paper
🔗http://bit.ly/3HkLhP6
Let’s unpack the findings ⤵️
Here's a🧵summarizing key aspects of paper
🔗http://bit.ly/3HkLhP6
Let’s unpack the findings ⤵️